WordNet
- defective bone development; usually attributable to renal disease or to disturbances in calcium and phosphorus metabolism
PrepTutorEJDIC
- 腎臓の
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 腎性骨異栄養症の骨生検および診断 bone biopsy and the diagnosis of renal osteodystrophy
- 2. 慢性腎臓病に伴う骨・ミネラル代謝異常（CKD-MBD）の概要 overview of chronic kidney disease mineral bone disease ckd mbd
- 3. 小児における慢性腎臓病のマネージメントの概要 overview of the management of chronic kidney disease in children
- 4. 成人における慢性腎臓病マネージメントの概要 overview of the management of chronic kidney disease in adults
- 5. カルシフィラキシス（calcific uremic arteriolopathy） calciphylaxis calcific uremic arteriolopathy
English Journal
- Uremic Leontiasis Ossea in a Patient With Chronic Renal Insufficiency Demonstrated on Bone Scintigraphy.
- Han YH1, Jeong HJ, Lim ST, Sohn MH.
- Clinical nuclear medicine.Clin Nucl Med.2016 Aug;41(8):641-2. doi: 10.1097/RLU.0000000000001262.
- A 37-year-old woman with chronic renal insufficiency underwent bone scintigraphy to evaluate renal osteodystrophy (ROD). Markedly increased uptakes were shown in the maxilla and the mandible, which suggested extensive maxillary and mandibular hypertrophy. CT image revealed that diffuse bony thickeni
- PMID 27276201
- Sclerostin levels in uremic patients: a link between bone and vascular disease.
- Bruzzese A1, Lacquaniti A1, Cernaro V1, Ricciardi CA1, Loddo S2, Romeo A1, Montalto G1, Costantino G1, Torre F1, Pettinato G1, Salamone I3, Aloisi C1, Santoro D1, Buemi M1.
- Renal failure.Ren Fail.2016 Jun;38(5):759-64. doi: 10.3109/0886022X.2016.1160207. Epub 2016 Mar 22.
- Sclerostin is a marker of low-turnover bone disease in end stage renal disease patients. The aim of this study was to evaluate serum sclerostin in uremic patients, analyzing its behavior during a single hemodialysis session. Twenty-one adult patients on intermittent hemodialysis treatment were enrol
- PMID 27001371
- Changing bone patterns with progression of chronic kidney disease.
- Drüeke TB1, Massy ZA2.
- Kidney international.Kidney Int.2016 Feb;89(2):289-302. doi: 10.1016/j.kint.2015.12.004.
- It is commonly held that osteitis fibrosa and mixed uremic osteodystrophy are the predominant forms of renal osteodystrophy in patients with chronic kidney disease. Osteitis fibrosa is a high-turnover bone disease resulting mainly from secondary hyperparathyroidism, and mixed uremic osteodystrophy i
- PMID 26806832
Japanese Journal
- Mutant FGF23 Prevents the Progression of Chronic Kidney Disease but Aggravates Renal Osteodystrophy in Uremic Rats
- Kusano Kenichiro,Saito Hitoshi,Segawa Hiroko [他],FUKUSHIMA Naoshi,MIYAMOTO Ken-ichi
- Journal of nutritional science and vitaminology 55(2), 99-105, 2009-04-01
- … FGF23 is a circulating factor that regulates renal phosphorus reabsorption and 1α-hydroxylase activity. … We focused on the phosphaturic activity of FGF23 and investigated whether a pharmacological dose of FGF23 is beneficial to the progression of renal insufficiency in uremic rats. … Chronic renal failure rats were established by intravenous injection of anti-rat CD90 (Thy1.1) monoclonal antibody to unilaterally nephrectomized Wistar rats. …
- NAID 10025970634
- Role of low protein and low phosphorus diet in the progression of chronic kidney disease in uremic rats
- Kusano Kenichiro,Segawa Hiroko,Ohnishi Ritsuko [他],FUKUSHIMA Naoshi,MIYAMOTO Ken-ichi
- Journal of nutritional science and vitaminology 54(3), 237-243, 2008-06
- … Restriction of dietary protein is useful for chronic kidney disease (CKD) patients to protect residual renal function. … The aim of this study is to compare the effect of protein and phosphorus on the progression of renal insufficiency using irreversible Thyl rats, which histopathologically resemble IgA nephropathy. … Renal function was assessed biochemically and histopathologically. …
- NAID 110006792025
- 二次性副甲状腺機能亢進症治療薬としてのマキサカルシトール
- 今関 郁夫
- 日本薬理学雑誌 121(1), 65-72, 2003-01-01
- マキサカルシトール（商品名オキサロール）はビタミンDの誘導体で，その適応症は注射剤としては維持透析下の二次性副甲状腺機能亢進症（2°HPT），軟膏としては尋常性乾癬，魚鱗癬群および掌蹠角化症である．このうち2°HPTは腎透析患者の主な合併症のひとつで，副甲状腺の腫大と副甲状腺ホルモン（PTH）の分泌過剰を引き起こす．一方，活性型ビタミンDである1α,25-dihydroxyvitamin D3（1 …
- NAID 10010252599
Related Links
- Renal Osteodystrophy · Constellation of musculoskeletal abnormalities occurring with chronic renal failure featuring some combination of o Osteomalacia (adults) o Rickets (children) o 2 ...
- In this chapter the term ‘renal osteodystrophy’ will be used in a generic sense to include all the clinical syndromes of skeletal disease and altered calcium (Ca) and phosphorus (P) homeostasis result
Related Pictures
★リンクテーブル★
| リンク元 | 「尿毒症性腎性骨異栄養症」 |
| 関連記事 | 「uremic」「renal osteodystrophy」「renal」「osteodystrophy」 |
「尿毒症性腎性骨異栄養症」
「uremic」
- adj.
- 尿毒症性の、尿毒症の、尿毒性の、尿毒の
「renal osteodystrophy」
[★] 腎性骨ジストロフィー 腎性骨異栄養症 renal osteodystrophy。腎性骨症
「renal」
- adj.
- 腎臓の、腎性の、腎の
「osteodystrophy」